Trial Profile
Add-on roflumilast in patients with severe COPD
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 29 Apr 2014 New trial record